Chembio Diagnostics (CEMI) Reports Q2 GAAP Loss of $0.86/Share
Tweet
Share
E-mailGet Alerts CEMI Hot Sheet
Price: $0.46 --0%
Financial Fact:
Cost of product sales: 1.79M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Cost of product sales: 1.79M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Chembio Diagnostics (NASDAQ: CEMI) reported Q2 EPS of ($0.86), versus ($0.07) reported last year. Revenue for the quarter came in at $3.27 million, versus $6.72 million reported last year.
The net loss in the 2016 period includes a tax provision for the recording of a valuation allowance on the Company's deferred tax asset of $5,963,000.
For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
- Greenlane Holdings Inc. (GNLN) reported Q2 result
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
